UNSPSC 51381505: Mesalamine or mesalazine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H7NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 4Q81I59GXC, chemically known as salicylic acid, 5-amino- but more generally known as mesalamine, which bears US NIH Compound Identifier 4075. European Medicines Agency schedules Mesalamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08782MIG.

The term MESALAZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules mesalamine in its Anatomical Therapeutic Chemical (ATC) Classification. Mesalamine bears US NLM identifiers UMLS ID C0127615 and NCI Concept Code C29249. SMILES: OC1C(CC(N)CC1)C(=O)O.

UNSPSC 51381505 Mesalamine or mesalazine is a Commodity code for a specific pharmaceutical product used in the treatment of inflammatory bowel disease, yet the most recent state and local contracting activity tagged to this code does not reflect pharmaceutical procurement. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking Naloxone and Safe Drug Deactivation Systems — emergency medical supplies and harm-reduction equipment unrelated to mesalamine scope. State and local governments buying under this code typically procure the mesalamine pharmaceutical itself for public health programs, emergency medical services, or institutional healthcare delivery, but the recent opportunities block shows no mesalamine-specific solicitations. The mismatch between the code's nominal scope and the tagged opportunity suggests either a tagging error in the underlying source data or minimal recent mesalamine procurement activity among state and local jurisdictions.

The geographic and issuing-body profile cannot be reliably characterized from a single unrelated opportunity. Seminole County, Florida's naloxone procurement does not represent mesalamine demand patterns. Without recent opportunities actually soliciting mesalamine products, the code shows insufficient current activity to support a market assessment for business development purposes.